Login to Your Account

Medicinova Gets the Green Light for MS Trial

By Catherine Shaffer
Staff Writer

Monday, July 22, 2013
Medicinova Inc. received funding and regulatory approval for a Phase IIb trial of its multiple sclerosis (MS) candidate, ibudilast.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription